174 related articles for article (PubMed ID: 3899398)
1. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
de Souza JM; Sheth UK; de Oliveira RM; Gomes AT; Cavalcante EQ
Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398
[TBL] [Abstract][Full Text] [Related]
2. A phase I clinical trial of mefloquine in Brazilian male subjects.
de Souza JM
Bull World Health Organ; 1983; 61(5):809-14. PubMed ID: 6360400
[TBL] [Abstract][Full Text] [Related]
3. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
[TBL] [Abstract][Full Text] [Related]
4. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
[TBL] [Abstract][Full Text] [Related]
5. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.
de Souza JM; Sheth UK; de Oliveira RM; Roulet H; de Souza SD
Bull World Health Organ; 1985; 63(3):603-9. PubMed ID: 3899397
[TBL] [Abstract][Full Text] [Related]
6. A phase II clinical trial of mefloquine in Brazilian male subjects.
de Souza JM
Bull World Health Organ; 1983; 61(5):815-20. PubMed ID: 6360401
[TBL] [Abstract][Full Text] [Related]
7. Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma.
Tin F; Hlaing N; Tun T; Win S; Lasserre R
Bull World Health Organ; 1985; 63(4):727-30. PubMed ID: 2935320
[TBL] [Abstract][Full Text] [Related]
8. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
Harinasuta T; Bunnag D; Vanijanond S; Charoenlarp P; Suntharasmai P; Chitamas S; Sheth UK; Wernsdorfer WH
Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439
[TBL] [Abstract][Full Text] [Related]
9. A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.
Ekue JM; Simooya OO; Sheth UK; Wernsdorfer WH; Njelesani EK
Bull World Health Organ; 1985; 63(2):339-43. PubMed ID: 3893778
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
[TBL] [Abstract][Full Text] [Related]
11. Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.
Bunnag D; Malikul S; Chittamas S; Chindanond D; Harinasuta T; Fernex M; Mittelholzer ML; Kristiansen S; Sturchler D
Southeast Asian J Trop Med Public Health; 1992 Dec; 23(4):777-82. PubMed ID: 1298089
[TBL] [Abstract][Full Text] [Related]
12. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
Kollaritsch H; Stemberger H; Mailer H; Kremsner P; Kollaritsch R; Leimer R; Wiedermann G
Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258
[TBL] [Abstract][Full Text] [Related]
13. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
Botero D; Restrepo M; Montoya A
Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296
[TBL] [Abstract][Full Text] [Related]
14. Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria.
Guo XB; Arnold K; Fu LC; Chen PQ; Li GQ
Trans R Soc Trop Med Hyg; 1988; 82(4):538-40. PubMed ID: 3076709
[TBL] [Abstract][Full Text] [Related]
15. The effect of mefloquine-sulfadoxine-pyrimethamine vs quinine on patients with complicated falciparum malaria.
Myint PT; Shwe T
Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):223-5. PubMed ID: 3313739
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef) in vivo and to mefloquine alone in vitro in Nigeria.
Salako LA; Aderounmu AF; Laoye JO; Makinde JM; Adio RA
Ann Trop Med Parasitol; 1988 Aug; 82(4):325-30. PubMed ID: 3075441
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial of fansimef in Indian patients of P. falciparum malaria.
Asthana OP; Tangri AN; Nityanand S
Indian J Malariol; 1988 Dec; 25(2):89-96. PubMed ID: 3077373
[No Abstract] [Full Text] [Related]
18. Phase III double-blind comparative study of Fansimef and Lariam for the curative treatment of Plasmodium falciparum infections in Thailand.
Thimasarn K; Pinichpongse S; Malikul S; Rooney W; Tansophalaks S
Southeast Asian J Trop Med Public Health; 1990 Sep; 21(3):404-11. PubMed ID: 2075482
[TBL] [Abstract][Full Text] [Related]
19. Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
Ellis-Pegler RB; Beeching NJ; Eales M; Fraser AG; Wells AU
Aust N Z J Med; 1988 Aug; 18(5):733-4. PubMed ID: 3072955
[No Abstract] [Full Text] [Related]
20. [A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance].
Niklewski G; Landscheidt H; Glasner H
Nervenarzt; 1985 Feb; 56(2):101-5. PubMed ID: 3885058
[No Abstract] [Full Text] [Related]
[Next] [New Search]